APO Research
Talk to an analyst

APO RESEARCH · REPORT

Injectable Drug Delivery Formulation

Compare research editions
View pricing & licenses

Selected research

Industry Research

Injectable Drug Delivery Formulation Industry Research Report 2026

22 December 2025116 pages

Choose your research edition.

Industry ResearchInjectable Drug Delivery Formulation Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Injectable Drug Delivery Formulation Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Injectable Drug Delivery Formulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injectable Drug Delivery Formulation Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Injectable Drug Delivery Formulation Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Injectable Drug Delivery Formulation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Injectable Drug Delivery Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Injectable Drug Delivery Formulation is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Injectable Drug Delivery Formulation is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Injectable Drug Delivery Formulation include Teva Pharmaceutical Industries Ltd. (Israel), Sandoz (Germany), Eli Lilly and Company (US), Pfizer, Inc. (US), Baxter International Inc. (US), Schott AG (Germany), Gerresheimer AG (Germany) and Becton, Dickinson and Company (US), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Injectable Drug Delivery Formulation market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Injectable Drug Delivery Formulation Market by Company

Teva Pharmaceutical Industries Ltd. (Israel)

Sandoz (Germany)

Eli Lilly and Company (US)

Pfizer, Inc. (US)

Baxter International Inc. (US)

Schott AG (Germany)

Gerresheimer AG (Germany)

Becton, Dickinson and Company (US)

Injectable Drug Delivery Formulation Segment by Type

Conventional Drug Delivery Formulations

Novel Drug Delivery Formulations

Long-acting Formulations

Injectable Drug Delivery Formulation Segment by Application

Orphan Diseases

Hormonal Disorders

Oncology

Autoimmune Diseases

Others

Injectable Drug Delivery Formulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Drug Delivery Formulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Drug Delivery Formulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Drug Delivery Formulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Injectable Drug Delivery Formulation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Injectable Drug Delivery Formulation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Injectable Drug Delivery Formulation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Injectable Drug Delivery Formulation Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Injectable Drug Delivery Formulation Sales (k units) of Manufacturers (2021-2026) Table 7. Global Injectable Drug Delivery Formulation Sales Market Share by Manufacturers (2021-2026) Table 8. Global Injectable Drug Delivery Formulation Revenue of Manufacturers (2021-2026) Table 9. Global Injectable Drug Delivery Formulation Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Injectable Drug Delivery Formulation Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Injectable Drug Delivery Formulation Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Injectable Drug Delivery Formulation, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Injectable Drug Delivery Formulation, Product Type & Application Table 14. Global Injectable Drug Delivery Formulation Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Injectable Drug Delivery Formulation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Pharmaceutical Industries Ltd. (Israel) Company Information Table 19. Teva Pharmaceutical Industries Ltd. (Israel) Business Overview Table 20. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Portfolio Table 22. Teva Pharmaceutical Industries Ltd. (Israel) Recent Developments Table 23. Sandoz (Germany) Company Information Table 24. Sandoz (Germany) Business Overview Table 25. Sandoz (Germany) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Sandoz (Germany) Injectable Drug Delivery Formulation Product Portfolio Table 27. Sandoz (Germany) Recent Developments Table 28. Eli Lilly and Company (US) Company Information Table 29. Eli Lilly and Company (US) Business Overview Table 30. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Portfolio Table 32. Eli Lilly and Company (US) Recent Developments Table 33. Pfizer, Inc. (US) Company Information Table 34. Pfizer, Inc. (US) Business Overview Table 35. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Portfolio Table 37. Pfizer, Inc. (US) Recent Developments Table 38. Baxter International Inc. (US) Company Information Table 39. Baxter International Inc. (US) Business Overview Table 40. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Portfolio Table 42. Baxter International Inc. (US) Recent Developments Table 43. Schott AG (Germany) Company Information Table 44. Schott AG (Germany) Business Overview Table 45. Schott AG (Germany) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Schott AG (Germany) Injectable Drug Delivery Formulation Product Portfolio Table 47. Schott AG (Germany) Recent Developments Table 48. Gerresheimer AG (Germany) Company Information Table 49. Gerresheimer AG (Germany) Business Overview Table 50. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Portfolio Table 52. Gerresheimer AG (Germany) Recent Developments Table 53. Becton, Dickinson and Company (US) Company Information Table 54. Becton, Dickinson and Company (US) Business Overview Table 55. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Portfolio Table 57. Becton, Dickinson and Company (US) Recent Developments Table 58. Global Injectable Drug Delivery Formulation Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 59. Global Injectable Drug Delivery Formulation Sales by Region (2021-2026) & (k units) Table 60. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2021-2026) Table 61. Global Injectable Drug Delivery Formulation Sales by Region (2027-2032) & (k units) Table 62. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2027-2032) Table 63. Global Injectable Drug Delivery Formulation Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2021-2026) Table 65. Global Injectable Drug Delivery Formulation Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2027-2032) Table 67. North America Injectable Drug Delivery Formulation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. North America Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 69. North America Injectable Drug Delivery Formulation Sales by Country (2027-2032) & (k units) Table 70. North America Injectable Drug Delivery Formulation Revenue by Country (2021-2026) & (US$ Million) Table 71. North America Injectable Drug Delivery Formulation Revenue by Country (2027-2032) & (US$ Million) Table 72. Europe Injectable Drug Delivery Formulation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Europe Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 74. Europe Injectable Drug Delivery Formulation Sales by Country (2027-2032) & (k units) Table 75. Europe Injectable Drug Delivery Formulation Revenue by Country (2021-2026) & (US$ Million) Table 76. Europe Injectable Drug Delivery Formulation Revenue by Country (2027-2032) & (US$ Million) Table 77. Asia Pacific Injectable Drug Delivery Formulation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Asia Pacific Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 79. Asia Pacific Injectable Drug Delivery Formulation Sales by Country (2027-2032) & (k units) Table 80. Asia Pacific Injectable Drug Delivery Formulation Revenue by Country (2021-2026) & (US$ Million) Table 81. Asia Pacific Injectable Drug Delivery Formulation Revenue by Country (2027-2032) & (US$ Million) Table 82. South America Injectable Drug Delivery Formulation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. South America Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 84. South America Injectable Drug Delivery Formulation Sales by Country (2027-2032) & (k units) Table 85. South America Injectable Drug Delivery Formulation Revenue by Country (2021-2026) & (US$ Million) Table 86. South America Injectable Drug Delivery Formulation Revenue by Country (2027-2032) & (US$ Million) Table 87. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2021-2026) & (k units) Table 89. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2027-2032) & (k units) Table 90. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country (2021-2026) & (US$ Million) Table 91. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country (2027-2032) & (US$ Million) Table 92. Global Injectable Drug Delivery Formulation Sales by Type (2021-2026) & (k units) Table 93. Global Injectable Drug Delivery Formulation Sales by Type (2027-2032) & (k units) Table 94. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2021-2026) Table 95. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2027-2032) Table 96. Global Injectable Drug Delivery Formulation Revenue by Type (2021-2026) & (US$ Million) Table 97. Global Injectable Drug Delivery Formulation Revenue by Type (2027-2032) & (US$ Million) Table 98. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2021-2026) Table 99. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2027-2032) Table 100. Global Injectable Drug Delivery Formulation Price by Type (2021-2026) & (US$/unit) Table 101. Global Injectable Drug Delivery Formulation Price by Type (2027-2032) & (US$/unit) Table 102. Global Injectable Drug Delivery Formulation Sales by Application (2021-2026) & (k units) Table 103. Global Injectable Drug Delivery Formulation Sales by Application (2027-2032) & (k units) Table 104. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2021-2026) Table 105. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2027-2032) Table 106. Global Injectable Drug Delivery Formulation Revenue by Application (2021-2026) & (US$ Million) Table 107. Global Injectable Drug Delivery Formulation Revenue by Application (2027-2032) & (US$ Million) Table 108. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2021-2026) Table 109. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2027-2032) Table 110. Global Injectable Drug Delivery Formulation Price by Application (2021-2026) & (US$/unit) Table 111. Global Injectable Drug Delivery Formulation Price by Application (2027-2032) & (US$/unit) Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Injectable Drug Delivery Formulation Distributors List Table 115. Injectable Drug Delivery Formulation Customers List Table 116. Injectable Drug Delivery Formulation Industry Trends Table 117. Injectable Drug Delivery Formulation Industry Drivers Table 118. Injectable Drug Delivery Formulation Industry Restraints Table 119. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Injectable Drug Delivery Formulation Product Image Figure 5. Global Injectable Drug Delivery Formulation Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Injectable Drug Delivery Formulation Market Size (2021-2032) & (US$ Million) Figure 7. Global Injectable Drug Delivery Formulation Sales (2021-2032) & (k units) Figure 8. Global Injectable Drug Delivery Formulation Average Price (US$/unit) & (2021-2032) Figure 9. Conventional Drug Delivery Formulations Product Image Figure 10. Novel Drug Delivery Formulations Product Image Figure 11. Long-acting Formulations Product Image Figure 12. Orphan Diseases Product Image Figure 13. Hormonal Disorders Product Image Figure 14. Oncology Product Image Figure 15. Autoimmune Diseases Product Image Figure 16. Others Product Image Figure 17. Global Injectable Drug Delivery Formulation Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Injectable Drug Delivery Formulation, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Injectable Drug Delivery Formulation Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Injectable Drug Delivery Formulation Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Injectable Drug Delivery Formulation Sales by Region in 2025 Figure 23. Global Injectable Drug Delivery Formulation Revenue by Region in 2025 Figure 24. North America Injectable Drug Delivery Formulation Market Size by Country in 2025 Figure 25. North America Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2032) Figure 26. North America Injectable Drug Delivery Formulation Revenue Market Share by Country (2021-2032) Figure 27. United States Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Injectable Drug Delivery Formulation Market Size by Country in 2025 Figure 31. Europe Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2032) Figure 32. Europe Injectable Drug Delivery Formulation Revenue Market Share by Country (2021-2032) Figure 33. Germany Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Injectable Drug Delivery Formulation Market Size by Country in 2025 Figure 44. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Injectable Drug Delivery Formulation Revenue Market Share by Country (2021-2032) Figure 46. China Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Injectable Drug Delivery Formulation Market Size by Country in 2025 Figure 55. South America Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2032) Figure 56. South America Injectable Drug Delivery Formulation Revenue Market Share by Country (2021-2032) Figure 57. Brazil Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Colombia Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Middle East and Africa Injectable Drug Delivery Formulation Market Size by Country in 2025 Figure 62. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Country (2021-2032) Figure 63. Middle East and Africa Injectable Drug Delivery Formulation Revenue Market Share by Country (2021-2032) Figure 64. Egypt Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. South Africa Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Israel Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Türkiye Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. GCC Countries Injectable Drug Delivery Formulation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2021-2032) Figure 70. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2021-2032) Figure 71. Global Injectable Drug Delivery Formulation Price (US$/unit) by Type (2021-2032) Figure 72. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2021-2032) Figure 73. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2021-2032) Figure 74. Global Injectable Drug Delivery Formulation Price (US$/unit) by Application (2021-2032) Figure 75. Injectable Drug Delivery Formulation Value Chain Figure 76. Injectable Drug Delivery Formulation Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Injectable Drug Delivery Formulation Industry Opportunities and Challenges

Scope & coverage.

Types
  • Conventional Drug Delivery Formulations
  • Novel Drug Delivery Formulations
  • Long-acting Formulations
Applications
  • Orphan Diseases
  • Hormonal Disorders
  • Oncology
  • Autoimmune Diseases
  • Others
Companies covered
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sandoz (Germany)
  • Eli Lilly and Company (US)
  • Pfizer, Inc. (US)
  • Baxter International Inc. (US)
  • Schott AG (Germany)
  • Gerresheimer AG (Germany)
  • Becton, Dickinson and Company (US)

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Injectable Drug Delivery Formulation Market Size (2021-2032)
  4. 2.2.2 Global Injectable Drug Delivery Formulation Sales (2021-2032)
  5. 2.2.3 Global Injectable Drug Delivery Formulation Market Average Price (2021-2032)
  6. 2.3 Injectable Drug Delivery Formulation by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Conventional Drug Delivery Formulations
  9. 2.3.3 Novel Drug Delivery Formulations
  10. 2.3.4 Long-acting Formulations
  11. 2.4 Injectable Drug Delivery Formulation by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Orphan Diseases
  14. 2.4.3 Hormonal Disorders
  15. 2.4.4 Oncology
  16. 2.4.5 Autoimmune Diseases
  17. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Injectable Drug Delivery Formulation Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Injectable Drug Delivery Formulation Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Injectable Drug Delivery Formulation Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Injectable Drug Delivery Formulation Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Injectable Drug Delivery Formulation Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Injectable Drug Delivery Formulation, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Injectable Drug Delivery Formulation, Product Type & Application
  8. 3.8 Global Manufacturers of Injectable Drug Delivery Formulation, Established Date
  9. 3.9 Global Injectable Drug Delivery Formulation Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva Pharmaceutical Industries Ltd. (Israel)
  2. 4.1.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Information
  3. 4.1.2 Teva Pharmaceutical Industries Ltd. (Israel) Business Overview
  4. 4.1.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Portfolio
  6. 4.1.5 Teva Pharmaceutical Industries Ltd. (Israel) Recent Developments
  7. 4.2 Sandoz (Germany)
  8. 4.2.1 Sandoz (Germany) Company Information
  9. 4.2.2 Sandoz (Germany) Business Overview
  10. 4.2.3 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sandoz (Germany) Injectable Drug Delivery Formulation Product Portfolio
  12. 4.2.5 Sandoz (Germany) Recent Developments
  13. 4.3 Eli Lilly and Company (US)
  14. 4.3.1 Eli Lilly and Company (US) Company Information
  15. 4.3.2 Eli Lilly and Company (US) Business Overview
  16. 4.3.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Portfolio
  18. 4.3.5 Eli Lilly and Company (US) Recent Developments
  19. 4.4 Pfizer, Inc. (US)
  20. 4.4.1 Pfizer, Inc. (US) Company Information
  21. 4.4.2 Pfizer, Inc. (US) Business Overview
  22. 4.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Portfolio
  24. 4.4.5 Pfizer, Inc. (US) Recent Developments
  25. 4.5 Baxter International Inc. (US)
  26. 4.5.1 Baxter International Inc. (US) Company Information
  27. 4.5.2 Baxter International Inc. (US) Business Overview
  28. 4.5.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Portfolio
  30. 4.5.5 Baxter International Inc. (US) Recent Developments
  31. 4.6 Schott AG (Germany)
  32. 4.6.1 Schott AG (Germany) Company Information
  33. 4.6.2 Schott AG (Germany) Business Overview
  34. 4.6.3 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Schott AG (Germany) Injectable Drug Delivery Formulation Product Portfolio
  36. 4.6.5 Schott AG (Germany) Recent Developments
  37. 4.7 Gerresheimer AG (Germany)
  38. 4.7.1 Gerresheimer AG (Germany) Company Information
  39. 4.7.2 Gerresheimer AG (Germany) Business Overview
  40. 4.7.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Portfolio
  42. 4.7.5 Gerresheimer AG (Germany) Recent Developments
  43. 4.8 Becton, Dickinson and Company (US)
  44. 4.8.1 Becton, Dickinson and Company (US) Company Information
  45. 4.8.2 Becton, Dickinson and Company (US) Business Overview
  46. 4.8.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Portfolio
  48. 4.8.5 Becton, Dickinson and Company (US) Recent Developments
5 Global Injectable Drug Delivery Formulation Market Scenario by Region
  1. 5.1 Global Injectable Drug Delivery Formulation Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Injectable Drug Delivery Formulation Sales by Region: 2021-2032
  3. 5.2.1 Global Injectable Drug Delivery Formulation Sales by Region: 2021-2026
  4. 5.2.2 Global Injectable Drug Delivery Formulation Sales by Region: 2027-2032
  5. 5.3 Global Injectable Drug Delivery Formulation Revenue by Region: 2021-2032
  6. 5.3.1 Global Injectable Drug Delivery Formulation Revenue by Region: 2021-2026
  7. 5.3.2 Global Injectable Drug Delivery Formulation Revenue by Region: 2027-2032
  8. 5.4 North America Injectable Drug Delivery Formulation Market Facts & Figures by Country
  9. 5.4.1 North America Injectable Drug Delivery Formulation Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Injectable Drug Delivery Formulation Sales by Country (2021-2032)
  11. 5.4.3 North America Injectable Drug Delivery Formulation Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Injectable Drug Delivery Formulation Market Facts & Figures by Country
  16. 5.5.1 Europe Injectable Drug Delivery Formulation Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Injectable Drug Delivery Formulation Sales by Country (2021-2032)
  18. 5.5.3 Europe Injectable Drug Delivery Formulation Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Injectable Drug Delivery Formulation Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Injectable Drug Delivery Formulation Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Injectable Drug Delivery Formulation Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Injectable Drug Delivery Formulation Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Injectable Drug Delivery Formulation Market Facts & Figures by Country
  41. 5.7.1 South America Injectable Drug Delivery Formulation Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Injectable Drug Delivery Formulation Sales by Country (2021-2032)
  43. 5.7.3 South America Injectable Drug Delivery Formulation Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Injectable Drug Delivery Formulation Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Injectable Drug Delivery Formulation Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Injectable Drug Delivery Formulation Sales by Type (2021-2032)
  2. 6.1.1 Global Injectable Drug Delivery Formulation Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Injectable Drug Delivery Formulation Sales Market Share by Type (2021-2032)
  4. 6.2 Global Injectable Drug Delivery Formulation Revenue by Type (2021-2032)
  5. 6.2.1 Global Injectable Drug Delivery Formulation Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Injectable Drug Delivery Formulation Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Injectable Drug Delivery Formulation Sales by Application (2021-2032)
  2. 7.1.1 Global Injectable Drug Delivery Formulation Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Injectable Drug Delivery Formulation Sales Market Share by Application (2021-2032)
  4. 7.2 Global Injectable Drug Delivery Formulation Revenue by Application (2021-2032)
  5. 7.2.1 Global Injectable Drug Delivery Formulation Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Injectable Drug Delivery Formulation Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Injectable Drug Delivery Formulation Value Chain Analysis
  2. 8.1.1 Injectable Drug Delivery Formulation Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Injectable Drug Delivery Formulation Production Mode & Process
  5. 8.2 Injectable Drug Delivery Formulation Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Injectable Drug Delivery Formulation Distributors
  8. 8.2.3 Injectable Drug Delivery Formulation Customers
9 Global Injectable Drug Delivery Formulation Analyzing Market Dynamics
  1. 9.1 Injectable Drug Delivery Formulation Industry Trends
  2. 9.2 Injectable Drug Delivery Formulation Industry Drivers
  3. 9.3 Injectable Drug Delivery Formulation Industry Opportunities and Challenges
  4. 9.4 Injectable Drug Delivery Formulation Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst